Merck's Ebola vaccine is 100% successful in interim Phase III results. fiercebiotech.com/story/mercks-e… by @DamianFierce $MRK $NLNK
Check out our rundown of the past year in FDA new drug approvals. 2014 brought a whopping 41 of them - fiercebiotech.com/special-report…
CAR-T 2.0: Small studies spotlight promise of a breakthrough upgrade. fiercebiotech.com/story/car-t-20… by @JohnCFierce $JUNO $KITE $NVS
Buzz: Cellectis could be in a line for a $1.6B Pfizer buyout. fiercebiotech.com/story/buzz-cel… by @DamianFierce $CLLS $PFE
The JP Morgan mood: Damn the valuations and full speed ahead in 2015 - fiercebiotech.com/story/jp-morga… by @JohnCFierce #JPM15
FierceBiotech's 2014 Fierce 15 - fiercebiotech.com/special-report… by @JohnCFierce, @DamianFierce. Congrats to those who made the list!
Special report: The 25 most influential people in biopharma in 2015. fiercebiotech.com/special-report…